| Literature DB >> 21501461 |
Toshiro Kobayashi1, Akihito Mikamo, Hiroshi Kurazumi, Ryo Suzuki, Bungo Shirasawa, Kimikazu Hamano.
Abstract
BACKGROUND: Deep sternal wound infection after cardiac surgery carries high morbidity and mortality. Our strategy for deep sternal wound infection is aggressive strenal debridement followed by vacuum-assisted closure (VAC) therapy and omental-muscle flap reconstrucion. We describe this strategy and examine the outcome and long-term quality of life (QOL) it achieves.Entities:
Mesh:
Year: 2011 PMID: 21501461 PMCID: PMC3094378 DOI: 10.1186/1749-8090-6-56
Source DB: PubMed Journal: J Cardiothorac Surg ISSN: 1749-8090 Impact factor: 1.637
Patients' characteristics
| Patient | Age (Years) | Gender | Risk factor | Primary procedure | Operation time |
|---|---|---|---|---|---|
| 1 | 61 | Male | DM | Cardiac trauma | 180 |
| 2 | 70 | Male | Smoking | CABG | 153 |
| 3 | 77 | Female | None | AVR | 270 |
| 4 | 65 | Male | None | CABG | 420 |
| 5 | 77 | Male | None | CABG | 428 |
| 6 | 72 | Male | DM | CABG | 445 |
| 7 | 71 | Male | DM | AVR | 300 |
| 8 | 67 | Male | HD | CABG | 340 |
| 9 | 59 | Male | None | Aorta | 595 |
| 10 | 87 | Female | None | AVR | 504 |
| 11 | 70 | Male | HD | CABG | 325 |
| 12 | 74 | Female | Steroid | Aorta | 470 |
| 13 | 61 | Female | Steroid | Aorta | 568 |
| 14 | 76 | Male | None | Aorta | 683 |
| 15 | 79 | Male | None | CABG | 342 |
| 16 | 62 | Male | None | Aorta | 496 |
CABG: Coronary artery bypass grafting, AVR: Aortic valve replacement,
Aorta: Thoracic Aortic surgery,
DM: Diabetes mellitus, Smoking: Currently smoking, HD: Chronic renal failure requiring hemodialysis, Steroid: Steroidal usage.
Characteristics of the deep sternal wound infections.
| Patient | Age (Years) | Gender | Risk factor | Primary procedure | Operation time (minutes) | Duration for treatment (days) | Pathogens | Follow up Period (months) | Prognosis | Cause of death |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 61 | Male | DM | Cardiac trauma | 180 | 150 | MRSA | 76.4 | Alive | - |
| 2 | 70 | Male | Smoking | CABG | 153 | 135 | MSSA | 78 | Alive | - |
| 3 | 77 | Female | None | AVR | 270 | 120 | MRSA | 63.4 | Alive | - |
| 4 | 65 | Male | None | CABG | 420 | 60 | MRSE | 64.8 | Death | Pneumonia |
| 5 | 77 | Male | None | CABG | 428 | 131 | MRSE | 50 | Alive | - |
| 6 | 72 | Male | DM | CABG | 445 | 124 | MRSA | 55.3 | Alive | - |
| 7 | 71 | Male | DM | AVR | 300 | Not available | MRSA | 0.57 | Death | DSWI |
| 8 | 67 | Male | HD | CABG | 340 | 37 | MRSA | 54 | Alive | - |
| 9 | 59 | Male | None | Aorta | 595 | 40 | Klebsiella | 54.8 | Alive | - |
| 10 | 87 | Female | None | AVR | 504 | 48 | MRSA | 4.8 | Death | Meningitis |
| 11 | 70 | Male | HD | CABG | 325 | 66 | MRSA | 12 | Death | Pneumonia |
| 12 | 74 | Female | Steroid | Aorta | 470 | 34 | MRSA | 37.1 | Alive | - |
| 13 | 61 | Female | Steroid | Aorta | 568 | 51 | Pseudomonaus | 31.2 | Alive | - |
| 14 | 76 | Male | None | Aorta | 683 | 66 | MSSA | 28.2 | Alive | - |
| 15 | 79 | Male | None | CABG | 342 | 203 | MRSA | 12.6 | Death | Pneumonia |
| 16 | 62 | Male | None | Aorta | 496 | 26 | MSSA | 11 | Alive | - |
Total: total sternectomy, Partial: partial sternectomy, None: sternectomy was not performed.
OF: Omental flap, PF: Pectralis major flap, VAC: VAC therapy
Primary: primary wound closure, Secondary: secondary wound closure.
MRSA: Methicillin-resistant Staphylococcus aureus, MRSE: Methicillin-resistant Staphylococcus epidermidis. Klebsiella: Klebsiella pneumoniae, Pseudomonas: Pseudomonas aeruginosa.
DSWI: Deep sternal wound infection.
Figure 1QOL of patients treated with total sternectomy. Age-, gender-, surgical procedures-, and follow-up period-matched comparison of the aspects assessed with the Short Form 36-Item Health Survey, Version 2 (SF36v2) in the patients who underwent total sternectomy (black bars) compared with patients who underwent cardiovascular surgery without DSWI (white bars). Score scales have a mean of 50 and a standard deviation of 10 in the 2002 Japanese general population.